The levels of estrogen and progesterone receptors, along with human epidermal growth factor receptor 2 (HER-2), have become key biomarkers in breast cancer treatment for hormone therapy and targeted HER-2 therapy. The gene discussed is PGR; the disease is breast carcinoma.